Hot Topics

Angie Szumlinski
|
January 19, 2022

Buprenorphine: Drug Safety Communication – FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain | FDA

Angie Szumlinski
|
January 19, 2022

FDA Clears Virtual Reality System to Ease Chronic Back Pain

Angie Szumlinski
|
January 18, 2022

National Nurses United- Tell OSHA: We need permanent protections against Covid-19!

Angie Szumlinski
|
January 18, 2022

Johnson & Johnson’s Janssen COVID-19 Vaccine Overview and Safety